Literature DB >> 3418664

Behçet's syndrome presenting as intracranial hypertension in a Caucasian.

M Cobby1, C M Higgs, C L Hall.   

Abstract

Entities:  

Mesh:

Year:  1988        PMID: 3418664      PMCID: PMC1291726          DOI: 10.1177/014107688808100824

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  8 in total

1.  Neuro-Behçet's syndrome in the United Arab Republic.

Authors:  M E Fadli; M M Youssef
Journal:  Eur Neurol       Date:  1973       Impact factor: 1.710

Review 2.  Behçet's disease. Report of twelve cases with three manifesting as papilledema.

Authors:  V V Kalbian; M T Challis
Journal:  Am J Med       Date:  1970-12       Impact factor: 4.965

3.  Behcet's disease. Presentation of 11 cases and evaluation of treatment.

Authors:  S Haim; K Sherf
Journal:  Isr J Med Sci       Date:  1966 Jan-Feb

4.  Neurological aspects of Behçet's disease. A case report and clinico-pathological review of the literature in Japan.

Authors:  H Kawakita; M Nishimura; Y Satoh; N Shibata
Journal:  J Neurol Sci       Date:  1967 Nov-Dec       Impact factor: 3.181

5.  Neurologic involvement in seven patients with Behçet's disease.

Authors:  J D O'Duffy; N P Goldstein
Journal:  Am J Med       Date:  1976-08       Impact factor: 4.965

6.  Behcet's syndrome in 32 patients in Yorkshire.

Authors:  M A Chamberlain
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

7.  [Cerebral venous thrombosis in Behçet's disease (author's transl)].

Authors:  M G Bousser; O Bletry; M Launay; E Portier; A Guillard; P Castaigne
Journal:  Rev Neurol (Paris)       Date:  1980       Impact factor: 2.607

Review 8.  Papilledema in Behçet's syndrome.

Authors:  M N Pamir; T Kansu; A Erbengi; T Zileli
Journal:  Arch Neurol       Date:  1981-10
  8 in total
  1 in total

1.  Behçet's syndrome treated with high-dose intravenous IgG and low-dose aspirin.

Authors:  E Rewald; J C Jaksic
Journal:  J R Soc Med       Date:  1990-10       Impact factor: 18.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.